SCHEMBL22019062

SCHEMBL22019062

Clc1cc2sc3c4ccccc4ccc3c2c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 6/20 0.48
CYP1A1 P04798 5/20 0.48
CYP1A2 P05177 7/20 0.44
MAPT P10636 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2A6 P11509 4/20 0.40
HPRT1 P00492 2/20 0.38
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
ALDH1A1 P00352 4/20 0.37
NQO1 P15559 1/20 0.36
NQO2 P16083 1/20 0.36
HSD17B10 Q99714 3/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HIF1A Q16665 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22650690 0.83 CYP2A6 (0.42) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL29364375 0.82 HPRT1 (0.46) CYP1B1CYP1A1CYP1A2L3MBTL1CYP2A6
SCHEMBL2150778 0.82 HPRT1 (0.46) CYP1B1CYP1A1CYP1A2L3MBTL1CYP2A6
SCHEMBL30612521 0.82 HPRT1 (0.46) CYP1B1CYP1A1CYP1A2L3MBTL1CYP2A6
SCHEMBL24156132 0.81 CYP1A1 (0.49) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL30020344 0.81 CYP1A1 (0.49) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL21936552 0.81 CYP1B1 (0.46) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL18810727 0.80 CYP1A1 (0.42) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL17383048 0.80 CYP1B1 (0.42) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1
SCHEMBL25733732 0.80 CYP1A1 (0.48) CYP1B1CYP1A1CYP1A2MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-01-20 US disclosed
WO-2020101169-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR51E2, OR10J3 CYP1B1 1379/4885CYP1A1 504/4885CYP1A2 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.